Healthy Living Maldives: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maldives.

Press releases published on July 7, 2026

Jul. 7, 2026

Ethos Laboratories Announces Exclusive U.S. Launch of CNSDose™, Following Successful MolDX® Technical Assessment

Indeterminate GlobeNewswire

Jul. 7, 2026

Lumanity Strengthens Climate Commitment with SBTi (Science Based Targets Initiative) Validation for Near-Term Emissions Reduction Targets

Indeterminate GlobeNewswire

Jul. 7, 2026

Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI

Indeterminate GlobeNewswire

Jul. 7, 2026

Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Indeterminate GlobeNewswire

Jul. 7, 2026

BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™

Indeterminate GlobeNewswire

Jul. 7, 2026

Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

Cytokinetics Announces Three Late-Breaking Science Abstracts at the European Society of Cardiology (ESC) Congress 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential

Indeterminate GlobeNewswire

Jul. 7, 2026

Alterity Therapeutics Receives FDA End-of-Phase 2 Meeting Minutes Confirming Registrational Pathway for ATH434 in Multiple System Atrophy

Indeterminate GlobeNewswire

Jul. 7, 2026

Teva to Advance Its Anti-IL-15 Antibody, Designed for Quarterly Dosing, Into Phase 2b Development in Vitiligo, Following Encouraging Phase 1b Results

Indeterminate GlobeNewswire

Jul. 7, 2026

HMNC Brain Health Announces Publication of Ketabon (KET01) Clinical Trial Results in JAMA Network Open

Indeterminate GlobeNewswire

Jul. 7, 2026

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

Indeterminate GlobeNewswire

Jul. 7, 2026

MariMed’s Nature’s Heritage Launches “The Nose Knows” Immersive, Science-Backed Consumer Education Campaign

Indeterminate GlobeNewswire

Jul. 7, 2026

Kymera Therapeutics Appoints Elizabeth Laws, Ph.D., as Senior Vice President, Global Program Team Leader for KT-621, First-in-Class, Oral STAT6 Degrader

Indeterminate GlobeNewswire

Jul. 7, 2026

Aclarion Announces Texas Spine Care Center as New CLARITY Site

Indeterminate GlobeNewswire

Jul. 7, 2026

ImageneBio Appoints Matt Robbins as General Counsel

Indeterminate GlobeNewswire

Jul. 7, 2026

U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease

Indeterminate GlobeNewswire

Jul. 7, 2026

Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease

Indeterminate GlobeNewswire

Jul. 7, 2026

AC Immune to Showcase Neurodegenerative Disease Pipeline with Three Presentations at AAIC® 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

Endogenex Announces Full Enrollment of the ReCET Clinical Study

Indeterminate GlobeNewswire